InterAx and Alveus collaborate on small-molecule metabolic treatment

The collaboration combines InterAx Biotech’s Deep Signal discovery platform with Alveus Therapeutics’ R&D capabilities in metabolic diseases. Credit: Sai Thaw Kyar / Shutterstock.com.